Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000438958

Medchemexpress LLC 3-Quinolineethanol, 6-bromo-α-(2,6-dimethoxy-4-pyridinyl)-α-[2-(dimethylamino)ethyl] | 2252316-16-6 | 99.7% | 614.50 | 1 ML
SDP

Catalog No. 5000438958
Encompass_Preferred

TBAJ-587 is a potent anti-tuberculosis agent that inhibits the growth of M.tb strain H37Rv with MIC90s of 0.006 and <0.02 μg/mL in MABA and LORA assays, respectively. It minimally inhibits the hERG channel, attenuating inhibition of the cardiac potassium channel protein coded by hERG, which is crucial for cardiac repolarization.

  • Potent anti-tuberculosis agent
  • Inhibits M.tb strain H37Rv growth
  • Minimally inhibits hERG channel
  • Attenuates inhibition of cardiac potassium channel protein
  • Analog of Bedaquiline with more potent anti-tubercular activity and greatly attenuated hERG blockade

Catalog No. 50-004-38958 Supplier Medchemexpress LLC Supplier No. HY11174710MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

TBAJ-587 is a potent anti-tuberculosis agent that inhibits the growth of M.tb strain H37Rv with MIC90s of 0.006 and <0.02 μg/mL in MABA and LORA assays, respectively. It minimally inhibits the hERG channel, attenuating inhibition of the cardiac potassium channel protein coded by hERG, which is crucial for cardiac repolarization.

  • Potent anti-tuberculosis agent
  • Inhibits M.tb strain H37Rv growth
  • Minimally inhibits hERG channel
  • Attenuates inhibition of cardiac potassium channel protein
  • Analog of Bedaquiline with more potent anti-tubercular activity and greatly attenuated hERG blockade

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.